Magic Bullet or Marginal Bet—Does Precision Medicine Offer the Best Hope for Sick Individuals and Sick Populations?
Philosophy of Science · 25.06.2026 · 1-13
DOI: 10.1017/psa.2026.10235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Philosophy of Science, online erschienen am 25.06.2026. Verfasst von Benjamin Chin-Yee und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
By targeting treatment according to molecular biomarkers, precision medicine promises a revolution in health care. We examine this promise by distinguishing three precision medicine strategies: biomarker-stratified high-risk-targeting, biomarker-based individual targeting, and biomarker-based disease targeting. Each strategy seeks to boost one of the determinants of the population impact of a medical intervention. We conclude that these strategies give a molecular coating to decades-old tactics. There is no compelling reason to believe that precision medicine strategies are uniquely effective for sick individuals or sick populations.
Zitieren
APA
Chin-Yee, B., & Fuller, J. (2026). Magic Bullet or Marginal Bet—Does Precision Medicine Offer the Best Hope for Sick Individuals and Sick Populations?. Philosophy of Science, 1-13. https://doi.org/10.1017/psa.2026.10235
Vancouver
Chin-Yee B, Fuller J. Magic Bullet or Marginal Bet—Does Precision Medicine Offer the Best Hope for Sick Individuals and Sick Populations?. Philosophy of Science. 2026:1-13. doi:10.1017/psa.2026.10235
BibTeX
@article{ChinYee2026,
author = {Chin-Yee, Benjamin and Fuller, Jonathan},
title = {Magic Bullet or Marginal Bet—Does Precision Medicine Offer the Best Hope for Sick Individuals and Sick Populations?},
journal = {Philosophy of Science},
year = {2026},
pages = {1--13},
doi = {10.1017/psa.2026.10235}
}
EUVIMED